Literature DB >> 24299989

Development of a highly sensitive, high-throughput assay for glycosyltransferases using enzyme-coupled fluorescence detection.

Kazuo Kumagai1, Hirotatsu Kojima2, Takayoshi Okabe2, Tetsuo Nagano2.   

Abstract

Glycosyltransferases catalyze transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. Identification of selective modulators of glycosyltransferases is important both to provide new tools for investigating pathophysiological roles of glycosylation reactions in cells and tissues, and as new leads in drug discovery. Here we describe a universal enzyme-coupled fluorescence assay for glycosyltransferases, based on quantification of nucleotides produced in the glycosyl transfer reaction. GDP, UDP, and CMP are phosphorylated with nucleotide kinase in the presence of excess ATP, generating ADP. Via coupled enzyme reactions involving ADP-hexokinase, glucose-6-phosphate dehydrogenase, and diaphorase, the ADP is utilized for conversion of resazurin to resorufin, which is determined by fluorescence measurement. The method was validated by comparison with an HPLC method, and employed to screen the LOPAC1280 library for inhibitors in a 384-well plate format. The assay performed well, with a Z'-factor of 0.80. We identified 12 hits for human galactosyltransferase B4GALT1 after elimination of false positives that inhibited the enzyme-coupled assay system. The assay components are all commercially available and the reagent cost is only 2 to 10 US cents per well. This method is suitable for low-cost, high-throughput assay of various glycosyltransferases and screening of glycosyltransferase modulators.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Enzyme-coupled assay; Fluorescence assay; Glycosyltransferase; High-throughput screening; Nucleotide determination

Mesh:

Substances:

Year:  2013        PMID: 24299989     DOI: 10.1016/j.ab.2013.11.025

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  CUPRA-ZYME: An Assay for Measuring Carbohydrate-Active Enzyme Activities, Pathways, and Substrate Specificities.

Authors:  Zhixiong Li; Pavel I Kitov; Elena N Kitova; Fahima Mozenah; Emily Rodrigues; Digantkumar G Chapla; Kelley W Moremen; Matthew S Macauley; John S Klassen
Journal:  Anal Chem       Date:  2020-02-07       Impact factor: 6.986

2.  A Sensitive Coupled Enzyme Assay for Measuring Kinase and ATPase Kinetics Using ADP-Specific Hexokinase.

Authors:  Ciaran R McFarlane; James W Murray
Journal:  Bio Protoc       Date:  2020-05-05

3.  Bacterial Glycosyltransferases: Challenges and Opportunities of a Highly Diverse Enzyme Class Toward Tailoring Natural Products.

Authors:  Jochen Schmid; Dominik Heider; Norma J Wendel; Nadine Sperl; Volker Sieber
Journal:  Front Microbiol       Date:  2016-02-18       Impact factor: 5.640

4.  Microbial production of next-generation stevia sweeteners.

Authors:  Kim Olsson; Simon Carlsen; Angelika Semmler; Ernesto Simón; Michael Dalgaard Mikkelsen; Birger Lindberg Møller
Journal:  Microb Cell Fact       Date:  2016-12-07       Impact factor: 5.328

5.  Efficient molecular evolution to generate enantioselective enzymes using a dual-channel microfluidic droplet screening platform.

Authors:  Fuqiang Ma; Meng Ting Chung; Yuan Yao; Robert Nidetz; Lap Man Lee; Allen P Liu; Yan Feng; Katsuo Kurabayashi; Guang-Yu Yang
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

6.  Entamoeba histolytica EHD1 Is Involved in Mitosome-Endosome Contact.

Authors:  Herbert J Santos; Yuki Hanadate; Kenichiro Imai; Haruo Watanabe; Tomoyoshi Nozaki
Journal:  mBio       Date:  2022-04-11       Impact factor: 7.786

7.  Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening.

Authors:  Masamitsu Harada; Jun Nagai; Riho Kurata; Kenji Shimizu; Xiaofeng Cui; Takayuki Isagawa; Hiroaki Semba; Jun Ishihara; Yasuhiro Yoshida; Norihiko Takeda; Koji Maemura; Tomo Yonezawa
Journal:  Mar Drugs       Date:  2020-03-13       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.